SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017505
Filing Date
2023-11-03
Accepted
2023-11-03 08:31:36
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20230930x10q.htm   iXBRL 10-Q 1274360
2 EX-10.1 glyc-20230930xex10d1.htm EX-10.1 22520
3 EX-31.1 glyc-20230930xex31d1.htm EX-31.1 16960
4 EX-31.2 glyc-20230930xex31d2.htm EX-31.2 16776
5 EX-32.1 glyc-20230930xex32d1.htm EX-32.1 9439
  Complete submission text file 0001558370-23-017505.txt   5347516

Data Files

Seq Description Document Type Size
6 EX-101.SCH glyc-20230930.xsd EX-101.SCH 34436
7 EX-101.CAL glyc-20230930_cal.xml EX-101.CAL 34845
8 EX-101.DEF glyc-20230930_def.xml EX-101.DEF 167631
9 EX-101.LAB glyc-20230930_lab.xml EX-101.LAB 348549
10 EX-101.PRE glyc-20230930_pre.xml EX-101.PRE 287344
54 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20230930x10q_htm.xml XML 850148
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 231374580
SIC: 2834 Pharmaceutical Preparations